S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
Best Bear Market Funds: Top 3 Investment Options to Consider
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
Best Bear Market Funds: Top 3 Investment Options to Consider
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
Best Bear Market Funds: Top 3 Investment Options to Consider
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
Best Bear Market Funds: Top 3 Investment Options to Consider
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
NASDAQ:BYSI

BeyondSpring (BYSI) Stock Price, News & Analysis

$3.63
+0.02 (+0.55%)
(As of 03/27/2024 ET)
Today's Range
$3.50
$3.69
50-Day Range
$0.87
$3.63
52-Week Range
$0.65
$4.00
Volume
64,095 shs
Average Volume
522,674 shs
Market Capitalization
$141.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.25

BeyondSpring MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
65.6% Downside
$1.25 Price Target
Short Interest
Bearish
9.90% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.29mentions of BeyondSpring in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.03 out of 5 stars

Medical Sector

935th out of 939 stocks

Pharmaceutical Preparations Industry

431st out of 433 stocks

BYSI stock logo

About BeyondSpring Stock (NASDAQ:BYSI)

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.

BYSI Stock Price History

BYSI Stock News Headlines

BYSI Oct 2024 7.500 call
This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
BYSI Mar 2024 7.500 call
Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
BeyondSpring Inc BYSI
BeyondSpring Stock (NASDAQ:BYSI) Insider Trades
Oncternal slips after early data for lymphoma therapy
See More Headlines
Receive BYSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BeyondSpring and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/29/2021
Today
3/28/2024
Next Earnings (Estimated)
4/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:BYSI
Employees
73
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.25
High Stock Price Target
$1.25
Low Stock Price Target
$1.25
Potential Upside/Downside
-65.6%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.35 million
Book Value
($0.36) per share

Miscellaneous

Free Float
27,515,000
Market Cap
$141.28 million
Optionable
Optionable
Beta
-0.05
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

BYSI Stock Analysis - Frequently Asked Questions

What is BeyondSpring's stock price target for 2024?

0 Wall Street research analysts have issued twelve-month target prices for BeyondSpring's shares. Their BYSI share price targets range from $1.25 to $1.25. On average, they predict the company's stock price to reach $1.25 in the next year. This suggests that the stock has a possible downside of 65.6%.
View analysts price targets for BYSI
or view top-rated stocks among Wall Street analysts.

How have BYSI shares performed in 2024?

BeyondSpring's stock was trading at $0.90 at the beginning of the year. Since then, BYSI shares have increased by 303.3% and is now trading at $3.63.
View the best growth stocks for 2024 here
.

Are investors shorting BeyondSpring?

BeyondSpring saw a increase in short interest in March. As of March 15th, there was short interest totaling 2,350,000 shares, an increase of 25.0% from the February 29th total of 1,880,000 shares. Based on an average daily trading volume, of 200,900 shares, the short-interest ratio is currently 11.7 days. Approximately 9.9% of the shares of the stock are sold short.
View BeyondSpring's Short Interest
.

When is BeyondSpring's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 16th 2024.
View our BYSI earnings forecast
.

How were BeyondSpring's earnings last quarter?

BeyondSpring Inc. (NASDAQ:BYSI) issued its earnings results on Wednesday, December, 29th. The company reported ($0.47) earnings per share for the quarter, topping the consensus estimate of ($0.58) by $0.11. The business earned $0.34 million during the quarter, compared to analyst estimates of $0.34 million.

What other stocks do shareholders of BeyondSpring own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BeyondSpring investors own include Exelixis (EXEL), Gilead Sciences (GILD), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Enterprise Products Partners (EPD), Johnson & Johnson (JNJ), Pfizer (PFE), Atara Biotherapeutics (ATRA), Dynavax Technologies (DVAX).

When did BeyondSpring IPO?

BeyondSpring (BYSI) raised $4 million in an initial public offering on Thursday, March 9th 2017. The company issued 200,000 shares at $20.00 per share. Rodman & Renshaw (a Unit of H.C. Wainwright & Co.) acted as the underwriter for the IPO.

Who are BeyondSpring's major shareholders?

BeyondSpring's stock is owned by many different retail and institutional investors. Top institutional shareholders include Decheng Capital LLC (12.74%), Capstone Capital Wealth Advisors (0.13%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of BeyondSpring?

Shares of BYSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BYSI) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners